Dolutegravir (DTG) is widely available in Ukraine due to the advocacy work of 100% LIFE, our campaign partner. The organization proactively advocated for DTG expansion, which led to the first ever procurement of generic DTG in Ukraine ever in 2017.
100% LIFE is Ukraine’s largest patient-led organization. It challenges unfair monopolies on essential medicines on a case-by-case basis, but also systematically.
Ukraine’s reformed patent law came into force this year, after years of advocacy work, and collaboration with government and patent offices. It provides a framework to prevent unlawful patents and monopolies on essential drugs, which have restricted access to life-saving treatment in the country.
“The outcome of 100% LIFE’s activism has helped fuel my health. In turn, my improved health has fuelled my activism,” says Andrei, 44, a minister of the Baptist Church in Ukraine.